Purpose: To find out the prevalence, and the risk factors conducive to the development of post-transplantation diabetes mellitus
(PTDM) after kidney allotransplantation (KAT).
Methods: The medical histories of 146 recipients of kidney allotransplants received between 1989 and 2014 were reviewed in
retrospect. Diabetes mellitus diagnosed before KAT was a criterion for exclusion from the study. Analysed as risk factors were: sex,
age, KAT time, and the use of glycocorticoids (GCs), tacrolimus (Tc), and/or cyclosporine A (CcA). The veritability of their influence
was assessed using the step-wise linear regression analysis method.
Results: The recipients’ average age was 42.9 +/- 20.2 (х±σ) years at the time of the study. PTDM prevalence in the general
group was 21.9% (n=32). Age and the use of calcineurin inhibitors (CNIs) and GCs had the greatest impact on PTDM development